DemocratAmendment · S.Amdt. 2111· Senate(119-SAMDT-2111)

S.Amdt. 2111

Rep. Klobuchar
Age: 66 years
Minnesota
Introduced
4/4/2025
Sponsored by
Amy Klobuchar
Cosponsors
None
Changes bill
119-HCONRES-14 — Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
  1. Introduced
  2. Pending Consideration

What this amendment would do

This amendment, submitted by Ms. Klobuchar, is officially known as SA 2111. Its purpose is to create a deficit-neutral reserve fund relating to research and product reviews by the Food and Drug Administration for rare diseases.

What It Aims to Change or Add

  • Allows the Chairman of the Committee on the Budget of the Senate to revise committee allocations, aggregates, and other appropriate levels in the resolution.
  • Permits adjustments to the pay-as-you-go ledger for legislation relating to research and product reviews by the Food and Drug Administration for rare diseases.
  • Supports efforts that may include accelerating the development and approval of treatments, improvements in regulatory science, or support for research on innovative therapies.
  • Requires that the legislation not increase the deficit over the period of the total of fiscal years 2025 through 2034.